May 2, 2007 by Brian LawlerVanda AdvancingVanda Pharmaceuticals releases first-quarter financial results.
May 2, 2007 by Brian LawlerBiogen's Measured GrowthDrugmaker Biogen Idec reports first-quarter financial results.
May 2, 2007 by Brian LawlerProgenics' Intriguing Study ResultsProgenics releases clinical trial results for one of its compound.
May 2, 2007 by Brian LawlerAnother Free Quarter of PainDrugmaker Pain Therapeutics announces first-quarter financial results.
May 1, 2007 by Brian LawlerPay Attention to NovenThe company is smart with its money, but is relying on one drug for some time.
May 1, 2007 by Brian LawlerCardiome Plays DealmakerCardiome signs a deal to develop one of Eli Lilly's drug candidates.
May 1, 2007 by Brian LawlerVertex Stays on PaceVertex Pharmaceuticals announces first-quarter financial results.
May 1, 2007 by Brian LawlerNorthfield Delays the InevitableNorthfield announces a delay in the analysis of a clinical trial for its drug candidate.
May 1, 2007 by Brian LawlerBristol-Myers Stops Spinning in PlaceBristol-Myers releases first-quarter financial results.
Apr 30, 2007 by Brian LawlerThe Future Millennium Isn't So ExcitingMillennium releases its quarterly financial results
Apr 30, 2007 by Brian LawlerAlexion Heads OverseasAlexion is headed for approval of its lead compound in the European Union.
Apr 30, 2007 by Brian LawlerNothing Wrong With EndoEndo Pharmaceuticals releases first-quarter financial results.
Apr 27, 2007 by Brian LawlerPDL Gets the Go-Ahead SignalPDL moves its lead compound into phase 3 testing.
Apr 27, 2007 by Brian LawlerTracking ImCloneDrugmaker ImClone Systems releases first-quarter financial results.
Apr 27, 2007 by Brian LawlerCephalon's Earnings SurpriseCephalon raises its earnings guidance for the year.
Apr 26, 2007 by Brian LawlerAstraZeneca's Announcement Overshadows EarningsAstraZeneca releases first-quarter financial results.
Apr 26, 2007 by Brian LawlerBrazil's Boneheaded Drug MoveBrazil's government announces that it may ignore existing patents for a top HIV treatment.
